GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
Capital International Investors
Los Angeles,
California
| $14.8B | -$2.29B | 6 | 3.06% | Reduced |
|
| 27 |
UBS AM
Chicago,
Illinois
| $13.8B | +$504M | 43 | 2.51% | Increased |
|
| 28 |
Bank of New York Mellon
New York
| $13.2B | -$285M | 55 | 2.17% | Reduced |
|
| 29 |
Amundi
Paris,
France
| $12.8B | -$392M | 26 | 3.08% | Reduced |
|
| 30 |
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
| $11.9B | -$21.4M | 65 | 2.61% | Reduced |
|
| 31 |
Fisher Asset Management
Camas,
Washington
| $11.8B | +$355M | 12 | 3.52% | Increased |
|
| 32 |
Royal Bank of Canada
Toronto,
Ontario, Canada
| $11.6B | -$39.1M | 65 | 1.72% | Reduced |
|
| 33 |
Nuveen
Charlotte,
North Carolina
| $11.2B | -$113M | 49 | 2.66% | Reduced |
|
| 34 |
Dimensional Fund Advisors
Austin,
Texas
| $10.1B | +$796M | 47 | 1.83% | Increased |
|
| 35 |
Wells Fargo
San Francisco,
California
| $10B | +$351M | 59 | 1.63% | Increased |
|
| 36 |
Jupiter Topco
New York
| $9.97B | +$9.1B | 39 | 4.06% | New |
|
| 37 |
Investor AB
Stockholm,
Sweden
| $9.78B | $0 | 1 | 67.92% | Maintained |
|
| 38 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $9.7B | -$199M | 51 | 2.82% | Reduced |
|
| 39 |
UBS Group
Zurich,
Switzerland
| $9.67B | -$193M | 73 | 1.23% | Reduced |
|
| 40 |
AllianceBernstein
Nashville,
Tennessee
| $7.37B | -$814M | 46 | 2.44% | Reduced |
|
| 41 |
Jennison Associates
New York
| $6.91B | +$264M | 7 | 4.14% | Increased |
|
| 42 |
Ameriprise
Minneapolis,
Minnesota
| $6.78B | -$331M | 44 | 1.37% | Reduced |
|
| 43 |
Vanguard Asset Management
London, Ec4n 8af,
| $6.73B | +$343M | 36 | 4.55% | Increased |
|
| 44 |
Berkshire Hathaway
Omaha,
Nebraska
| $6.43B | -$222M | 1 | 2.15% | Reduced |
|
| 45 |
Massachusetts Financial Services
Boston,
Massachusetts
| $6.08B | -$184M | 13 | 1.93% | Reduced |
|
| 46 |
Swiss National Bank
Zurich,
Switzerland
| $5.77B | -$213M | 35 | 3.02% | Reduced |
|
| 47 |
DZ Bank
Frankfurt Am Main,
Germany
| $5.21B | +$301M | 14 | 4% | Increased |
|
| 48 |
Barclays
London,
United Kingdom
| $4.76B | -$416M | 64 | 0.91% | Reduced |
|
| 49 |
AQR Capital Management
Greenwich,
Connecticut
| $4.52B | +$824M | 47 | 1.58% | Increased |
|
| 50 |
Arrowstreet Capital
Boston,
Massachusetts
| $4.32B | +$773M | 27 | 1.91% | Increased |
|